These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 26436169

  • 1. Mechanisms of action of amphetamine-like drugs.
    Prescrire Int; 2015 Jun; 24(161):155. PubMed ID: 26436169
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amphetamine-type medicines: a review of pharmacokinetics, pharmacodynamics, and toxicological aspects.
    Mariotti KC, Rossato LG, Fröehlich PE, Limberger RP.
    Curr Clin Pharmacol; 2013 Nov; 8(4):350-7. PubMed ID: 23342978
    [Abstract] [Full Text] [Related]

  • 4. New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems.
    Welter-Luedeke J, Maurer HH.
    Ther Drug Monit; 2016 Feb; 38(1):4-11. PubMed ID: 26327309
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress.
    Brown JM, Yamamoto BK.
    Pharmacol Ther; 2003 Jul; 99(1):45-53. PubMed ID: 12804698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Delusional infestation following misuse of prescription stimulants.
    Stanciu CN, Penders TM, Oxentine HN.
    Psychosomatics; 2015 Jul; 56(2):210-2. PubMed ID: 25262039
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh").
    Glennon RA, Misenheimer B.
    Pharmacol Biochem Behav; 1990 Mar; 35(3):517-21. PubMed ID: 1971111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. General anesthesia and chronic amphetamine use: should the drug be stopped preoperatively?
    Fischer SP, Schmiesing CA, Guta CG, Brock-Utne JG.
    Anesth Analg; 2006 Jul; 103(1):203-6, table of contents. PubMed ID: 16790654
    [Abstract] [Full Text] [Related]

  • 16. [Psychiatric illness associated with amphetamines and other stimulants].
    Fischer RB.
    Psychiatr Prax; 2000 May; 27(4):203. PubMed ID: 17195515
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Designer psychostimulants: pharmacology and differences.
    Iversen L, White M, Treble R.
    Neuropharmacology; 2014 Dec; 87():59-65. PubMed ID: 24456744
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.